Our cell-free, synthetic resorbable arteriovenous (AV) graft for dialysis access serves as the foundation for vascular conduit replacement. It eliminates the need for tissue donation, immune suppressants, and transplant rejection. The graft degrades over time while creating new native tissue fistula for continual dialysis access. The graft match's the native artery/vein to which it attaches while achieving stasis faster than competing products.